After another strong quarter, CVS raises outlook for 2022

COVID-19 VACCINES and tests for the virus continued to boost CVS Health in the first quarter, and the health care giant finally raised its annual forecast. The drugstore chain and pharmacy benefit manager said Wednesday, May 4, 2022, that it now expects earnings of $8.20 to $8.40 per share for 2022. / GENE J. PUSKAR / ASSOCIATED PRESS
COVID-19 vaccines and tests for the virus continue to boost CVS Health Corp. and the health care giant raised its annual forecast after yet another strong quarter. The drugstore chain and pharmacy benefit manager also processed more prescriptions and added customers to its health insurance business in a better-than-expected performance. "Our strategy improves access to…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display